Enhancing insulin sensitivity by reducing adipocyte senescence using uPAR-targeted nanoparticles in high-fat-diet-induced obese mice
Journal of Controlled Release · 2026
DOI: 10.1016/j.jconrel.2026.115178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026. Verfasst von Jin Ki Jung und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea; Senotherapy-based Metabolic Disease Control Resea…. Hauptthemen laut MEDLINE: Dasatinib, Obesity, Adipocytes, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
The urokinase-type plasminogen activator receptor (uPAR) is a glycosylphosphatidylinositol-anchored membrane protein that regulates fibrinolysis, cell adhesion, migration, and intracellular signaling. Elevated uPAR expression is linked to numerous pathological conditions, including cancer, inflammation, and metabolic dysfunction. In obesity and aging, increased uPAR levels are associated with chronic inflammation, adipose tissue impairment, and systemic metabolic disturbances. uPAR also modulates adipocyte differentiation and contributes to the progression of inflammatory obesity, while serving as a key regulator of cellular senescence triggered by oncogenic stress, chemotherapy, or aging. These characteristics position uPAR as a compelling therapeutic target for metabolic and age-related diseases. To address this, we developed a nanoparticle-based targeted therapy optimized for senolytic delivery, which enhances accumulation in uPAR-overexpressing cells and improves drug stability. Dasatinib and quercetin, two established senolytic agents, were co-encapsulated into uPAR-targeted hybrid nanoparticles to selectively eliminate senescent cells, reduce inflammation, and restore metabolic homeostasis, presenting a promising therapeutic strategy for obesity- and aging-associated disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea; Senotherapy-based Metabolic Disease Control Research Center, College of Medicine, Yeungnam University, Daegu 42415, Rep…
- Senotherapy-based Metabolic Disease Control Research Center, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea; College of Pharmacy, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic o…
- Department of Chemical Engineering, School of Chemistry and Life Sciences, Hanoi University of Science and Technology, 1 Dai Co Viet, Hanoi 10000, Viet Nam.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jung, J. K., Nguyen, T. O. O., Jung, W. C., Nguyen, B. L., Le, N. D., Kim, B., Luong, H. X., Park, S., Jeong, S. Y., Kim, J., Kim, J. O., & Park, S. Y. (2026). Enhancing insulin sensitivity by reducing adipocyte senescence using uPAR-targeted nanoparticles in high-fat-diet-induced obese mice. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115178
Vancouver
Jung JK, Nguyen TOO, Jung WC, Nguyen BL, Le ND, Kim B, et al. Enhancing insulin sensitivity by reducing adipocyte senescence using uPAR-targeted nanoparticles in high-fat-diet-induced obese mice. Journal of Controlled Release. 2026. doi:10.1016/j.jconrel.2026.115178
BibTeX
@article{Jung2026,
author = {Jung, Jin Ki and Nguyen, Thi Oanh Oanh and Jung, Won Chul and Nguyen, Bao Loc and Le, Ngoc Duy and Kim, Beomsu and Luong, Huy Xuan and Park, Soyoung and Jeong, Su-Yeon and Kim, Jeonghwan and Kim, Jong Oh and Park, So-Young},
title = {Enhancing insulin sensitivity by reducing adipocyte senescence using uPAR-targeted nanoparticles in high-fat-diet-induced obese mice},
journal = {Journal of Controlled Release},
year = {2026},
doi = {10.1016/j.jconrel.2026.115178}
}
EUVIMED